Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00171535 · ClinicalTrials.gov registry record · Phase 3
Efficacy and Safety of Valsartan/Amlodipine Combination in Patients With Severe Hypertension
A Phase 3 study, sponsored by Novartis.
- Completed
- Registry status
- Phase 3
- Development phase
- 130
- Enrollment target
NCT00171535 is a Phase 3 study that has completed, run by Novartis. The registered enrollment target is 130 participants.
The verdict
NCT00171535, a Phase 3 study, has completed, sponsored by Novartis.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 130 participants
- Enrollment target
Study Summary
This study will assess the effectiveness and safety of different combination antihypertensive treatments in patients with severe hypertension
Interventions
- DRUG valsartan/amlodipine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2004-10 |
| Est. Completion | 2005-04 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00171535
The ClinicalTrials.gov registry entry for NCT00171535 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novartis, which has 265 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which valsartan/amlodipine is the first listed.
NCT00171535 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00171535 about?
NCT00171535 is a clinical study titled "Efficacy and Safety of Valsartan/Amlodipine Combination in Patients With Severe Hypertension". This study will assess the effectiveness and safety of different combination antihypertensive treatments in patients with severe hypertension
What is the current status of trial NCT00171535?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 130 participants. The study started on 2004-10. Estimated completion is 2005-04.
What interventions are being tested in trial NCT00171535?
The interventions under investigation include: valsartan/amlodipine (DRUG).
Who is sponsoring clinical trial NCT00171535?
This trial is sponsored by Novartis, which has 265 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.